Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypes in pulmonary hypertension.

The European respiratory journal - 1 Sept 2024

Weatherald Jason, Hemnes Anna R, Maron Bradley A, Mielniczuk Lisa M, Gerges Christian, Price Laura C, Hoeper Marius M, Humbert Marc

Abstract excerpt

The clinical classification of pulmonary hypertension (PH) has guided diagnosis and treatment of patients with PH for several decades. Discoveries relating to underlying mechanisms, pathobiology and responses to treatments for PH have informed the evolution in this clinical classification to describe the heterogeneity in PH phenotypes. In more recent years, advances in imaging, computational science and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Function and Risk Factors
Share to Hypertension, Pulmonary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neonatal Respiratory Health Research

Share to Phenotype

Share to Prognosis

Share to Pulmonary Arterial Hypertension

Share to Pulmonary Hypertension Research and Treatments

Source

Identifiers

PMID: 38964779
DOI: 10.1183/13993003.01633-2023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypes in pulmonary hypertension.PMID 38964779Read ↗

An official American Thoracic Society Statement: pulmonary hypertension phenotypes.Semantic proximity Read ↗

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary HypertensionSemantic proximity Read ↗

Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.Semantic proximity Read ↗

Using Omics to Understand and Treat Pulmonary Vascular DiseaseSemantic proximity Read ↗

Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.Semantic proximity Read ↗

Genetic variants in pulmonary hypertension associated with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.Semantic proximity Read ↗

Exploring hypoxia driven subtypes of pulmonary arterial hypertension through transcriptomics single cell sequencing and machine learningSemantic proximity Read ↗

Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets-From Bench to Bed Site.Semantic proximity Read ↗

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertensionSemantic proximity Read ↗

Artificial Intelligence and Multi-Omics Integration in the Precision Management of Pulmonary Hypertension: From Early Diagnosis to Therapeutic StratificationSemantic proximity Read ↗

The 6th World Symposium on Pulmonary Hypertension: what’s old is newSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.